Literature DB >> 3034599

Characterization of recombinant human granulocyte-colony-stimulating factor produced in mouse cells.

M Tsuchiya, H Nomura, S Asano, Y Kaziro, S Nagata.   

Abstract

Mouse C127I cells were transformed with a chimeric plasmid consisting of bovine papillomavirus DNA and human granulocyte-colony-stimulating factor (G-CSF) cDNA placed under the control of the SV40 early promoter. The transformed cells secreted constitutively a high level of human G-CSF, 10-20 micrograms/ml in a low-serum medium. The secreted G-CSF has been purified to homogeneity by a two-step procedure including gel filtration and hydrophobic column chromatography. The purified recombinant G-CSF runs as a single band with an apparent Mr of 19,000 on a polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate. This value corresponds to that of the native human G-CSF purified from the medium conditioned by human carcinoma CHU-2 cells. The recombinant human G-CSF was as active as native G-CSF in vitro in supporting proliferation of mouse NFS-60 cells and stimulating colony formation from human as well as mouse bone marrow cells. When the recombinant human G-CSF was subcutaneously administrated into mice, a remarkable stimulation of granulopoiesis and splenomegaly was observed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3034599      PMCID: PMC553441          DOI: 10.1002/j.1460-2075.1987.tb04798.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  27 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue.

Authors:  S Asano; A Urabe; T Okabe; N Sato; Y Kondo
Journal:  Blood       Date:  1977-05       Impact factor: 22.113

5.  Transformation of mouse fibroblasts to methotrexate resistance by a recombinant plasmid expressing a prokaryotic dihydrofolate reductase.

Authors:  K O'Hare; C Benoist; R Breathnach
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

6.  Transformation and replication in mouse cells of a bovine papillomavirus--pML2 plasmid vector that can be rescued in bacteria.

Authors:  N Sarver; J C Byrne; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

7.  A new mass-spectrometric C-terminal sequencing technique finds a similarity between gamma-interferon and alpha 2-interferon and identifies a proteolytically clipped gamma-interferon that retains full antiviral activity.

Authors:  K Rose; M G Simona; R E Offord; C P Prior; B Otto; D R Thatcher
Journal:  Biochem J       Date:  1983-11-01       Impact factor: 3.857

8.  Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor.

Authors:  N A Nicola; D Metcalf; M Matsumoto; G R Johnson
Journal:  J Biol Chem       Date:  1983-07-25       Impact factor: 5.157

9.  Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences.

Authors:  M F Law; D R Lowy; I Dvoretzky; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

10.  Growth of factor-dependent hemopoietic precursor cell lines.

Authors:  T M Dexter; J Garland; D Scott; E Scolnick; D Metcalf
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Preclinical and clinical studies with the hematopoietic colony-stimulating factors and related interleukins.

Authors:  H E Broxmeyer; S Vadhan-Raj
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 2.  Colony-stimulating factors in the pathogenesis and treatment of disease.

Authors:  D J Williamson; C G Begley
Journal:  Postgrad Med J       Date:  1987-12       Impact factor: 2.401

3.  Characterization of recombinant-derived granulocyte-colony stimulating factor (G-CSF).

Authors:  P Wingfield; R Benedict; G Turcatti; B Allet; J J Mermod; J DeLamarter; M G Simona; K Rose
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

4.  High-level expression of a cDNA for human granulocyte colony-stimulating factor in Chinese hamster ovary cells. Effect of 3'-noncoding sequences.

Authors:  L Rotondaro; L Mazzanti; A Mele; G Rovera
Journal:  Mol Biotechnol       Date:  1997-06       Impact factor: 2.695

5.  Human granulocyte colony-stimulating factor (hG-CSF) expression in plastids of Lactuca sativa.

Authors:  Mehdi Sharifi Tabar; Ali Akbar Habashi; Hamid Rajabi Memari
Journal:  Iran Biomed J       Date:  2013

6.  Functional domains of the granulocyte colony-stimulating factor receptor.

Authors:  R Fukunaga; E Ishizaka-Ikeda; C X Pan; Y Seto; S Nagata
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

7.  Ubiquitin fusion expression and tissue-dependent targeting of hG-CSF in transgenic tobacco.

Authors:  Li Tian; Samuel Sm Sun
Journal:  BMC Biotechnol       Date:  2011-10-11       Impact factor: 2.563

8.  Proliferative effect of human granulocyte colony-stimulating factor on blast cells of acute promyelocytic leukemia.

Authors:  K Kitano; T Suda; Y Sato; Y Miura
Journal:  Jpn J Cancer Res       Date:  1988-07

9.  Granulocyte-colony stimulating factor and retinoic acid cooperatively induce granulocyte differentiation of acute promyelocytic leukemia cells in vitro.

Authors:  T Nakamaki; A Sakashita; M Sano; K Hino; K Suzuki; S Tomoyasu; N Tsuruoka; Y Honma; M Hozumi
Journal:  Jpn J Cancer Res       Date:  1989-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.